Plant Advanced Technologies

ALPAT

FR0010785790

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:04:47 2024-04-30 am EDT			5-day change	1st Jan Change
11.4 ^EUR	+7.55%		+12.87%	+34.91%

Jan. 09	Plant Advanced Technologies Announces the Official Launch of Its Latest Active Ingredient, Hydraqueen Exudactive®?1,3, and the Upcoming Cosmetic Range as Part of Its New Business Strategy	CI
2023	Plant Advanced Technologies SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Plant Advanced Technologies SA Announces Revenue Results for the Year 2020

March 15, 2021 at 12:02 pm EDT

Plant Advanced Technologies SA announced revenue results for the year 2020. Annual revenue up 7% to €1.26 million compared to €1.17 million in 2019.

Latest news about Plant Advanced Technologies

Plant Advanced Technologies Announces the Official Launch of Its Latest Active Ingredient, Hydraqueen Exudactive®?1,3, and the Upcoming Cosmetic Range as Part of Its New Business Strategy	Jan. 09	CI
Plant Advanced Technologies SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-30	CI
Global markets live: Warner, Givaudan, Apple, Tesla, AMC...	23-04-04
Global markets live: Haleon, Best Buy, Macy's, HSBC, GSK...	23-03-02
Plant Advanced Technologies SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-11-02	CI
Plant Advanced Technologies SA Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-30	CI
Plant Advanced Technologies SA Reports Earnings Results for the Half Year Ended June 30, 2021	21-10-30	CI
Global markets live: BNP Paribas, Ubisoft, Amazon, Chevron, Coca-Cola...	21-10-29
Plant Advanced Technologies SA Reports Consolidated Earnings Results for the Year Ended December 31, 2020	21-06-17	CI
Plant Advanced Technologies Sa Announces Financial Results for the Year Ended December 31, 2020	21-05-05	CI
Global markets live: Verizon, Pandora, HelloFresh...	21-05-04
Plant Advanced Technologies PAT Announces the Discovery of a New Class of Plant Enzymes, Published in Exclusivity in the Scientific Journal, PNAS(1), in Partnership With Kyoto University and the University of Lorraine	21-05-03	CI
Plant Advanced Technologies SA Announces Revenue Results for the Year 2020	21-03-15	CI
Plant Advanced Technologies SA Provides Revenue Guidance for the Year 2021	21-03-15	CI
CO2 GRO Inc. Announces a Commercial Feasibility with Plant Advanced Technologies PAT in France in Conjunction with Rika Biotech	21-01-28	CI
Temisis Therapeutics announced that it has received €1.6 million in funding from Financiere Hoche Bains-Les-Bains SA, Plant Advanced Technologies SA	20-12-17	CI
Plant Advanced Technologies Announces Creation of Subsidiary Cellengo	20-03-06	CI
Plant Advanced Technologies : Clariant and Plant Advanced Technologies agree strategic partnership in cosmetics	19-11-29	RE
Plant Advanced Technologies SA announced that it has received funding from Clariant AG	19-11-28	CI
Plant Advanced Technologies SA announced that it has received funding from FLC - ILP - Sadepar Gestion and other investors	18-12-25	CI
Plant Advanced Technologies Announces Board Appointments	18-08-02	CI
Plant Advanced Technologies SA Reports Unaudited Sales Results for the First Half Ended June 30, 2018	18-07-25	CI
Plant Advanced Technologies PAT Announces New Distribution Agreement with Safic-Alcan	18-04-12	CI
Plant Advanced Technologies Announces Creation of TEMISIS Subsidiary	18-02-09	CI
Plant Advanced Technologies SA announced that it has received €0.5 million in funding from Vetoquinol SA	17-11-12	CI

Chart Plant Advanced Technologies

Duration

Period

More charts

Plant Advanced Technologies specializes in the identification, optimization and production of rare biomolecules for the pharmaceutical laboratories, cosmetic industries and green chemistry. The group has developed revolutionary production methods based on aeroponics growing plant (soilless). Innovative technologies (PAT plantes à traire - Patent INRA-University of Lorraine / INPL and PAT Friday) allow the identification of new rare molecules previously inaccessible and the industrial production.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Ratings for Plant Advanced Technologies

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

11.4 EUR

Average target price

11.5 EUR

Spread / Average Target

+0.88%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
PLANT ADVANCED TECHNOLOGIES	+34.91%	13.25M
IQVIA HOLDINGS INC.	+1.17%	42.19B
LONZA GROUP AG	+44.30%	40.15B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+6.88%	24.63B
ALNYLAM PHARMACEUTICALS, INC.	-22.05%	18.2B
MEDPACE HOLDINGS, INC.	+29.15%	12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.24%	11.76B
UNITED THERAPEUTICS CORPORATION	+15.50%	10.4B
BIO-TECHNE CORPORATION	-4.30%	9.94B

Other Biotechnology & Medical Research